Clinical Trial Update: Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of adoptive T cell therapy using activated P53-specific T cells for advanced colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Activated P53-specific T cells (p53-specific T cells)

Snippet

Sponsor: National Center for Tumor Diseases, Heidelberg | Conditions: Colorectal Carcinoma | Phase 1 | Status: TERMINATED